Bio-Techne Corp. Stock
Price
Target price
€58.50
€58.50
-2.520%
-1.5
-2.520%
€75.80
25.04.24 / Tradegate
WKN: A12ENG / Symbol: TECH / Name: Bio-Techne / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Bio-Techne Corp. Stock
A loss of -2.520% shows a downward development for Bio-Techne Corp..
Bio-Techne Corp. is currently one of the favorites of our community with 8 Buy predictions and no Sell predictions.
As a result the target price of 75 € shows a positive potential of 28.21% compared to the current price of 58.5 € for Bio-Techne Corp..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Bio-Techne Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Bio-Techne Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Techne Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Techne Corp. | -2.520% | -4.032% | -10.526% | -20.667% | -16.197% | - | - |
| Neogen Corp. | 3.670% | -3.540% | -22.695% | -29.677% | -40.437% | -72.405% | -57.414% |
| Bio-Rad Labs Inc. A | -0.920% | -4.622% | -19.901% | -37.859% | -11.444% | -50.943% | - |
| Merit Medical Systems | - | 2.985% | 3.759% | -2.817% | 1.471% | 33.981% | 35.480% |
Comments
Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at Stephens from $92.00 to $87.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $80.00 price target on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at Stifel Nicolaus from $104.00 to $65.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat